ADVERTISEMENT
Will The Stellar Run Of Diagnostic Stocks Continue?
The optimism about diagnostic businesses contrasts with the rest of the healthcare market.
11 Sep 2019, 02:53 PM IST
Shares of India’s two largest pathology chains by market value have returned the best gains so far this year in a bleeding pharma-healthcare market as investors bet on rising spends on diagnostics.Dr Lal Pathlabs Ltd. and Metropolis Healthcare Ltd. are trading at record levels despite their costliest valuations in the sector, surging 43 percent and 49 percent in 2019. That compares with a 9 percent decline in the Nifty Pharma Index.A...
I’m already a Subscriber Sign In
To continue reading this story
Subscribe to unlock & enjoy all Members-only benefits
Choose a plan
Renews automatically. Cancel anytime.
As a Subscriber you get
Full Access to
NDTV Profit App
Exclusives
Premium Stories
Access to
Stories
Curated
Newsletters
20,000+
Research Reports
Priority Pass
to Special Events
Ad-Free
Experience
Members-Only
Rewards
Still Not convinced ? Know More
Get live Stock market updates, Business news, Today’s latest news, Trending stories, and Videos on NDTV Profit.
ADVERTISEMENT